Evidence map›Paper›PMID 35744752›Full record

ArticleMicroorganisms2022

Distinguishing

Catarina Gouveia, Ana Subtil, Susana Norte, Joana Arcangelo, Madalena Almeida Santos, Rita Corte-Real, Maria João Simões, Helena Canhão, Delfin Tavares

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Microorganisms · 2022
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Catarina GouveiaInfectious Diseases Unit, Hospital de Dona Estefânia, Centro Hospitalar Universitário Lisboa Central, 1169-045 Lisbon, Portugal.ORCID 0000-0002-4162-8473
Ana SubtilNOVA National School of Public Health, Comprehensive Health Research Center, CHRC, NOVA University Lisbon, 1600-560 Lisbon, Portugal.
Susana NortePediatric Orthopedic Unit, Área de Pediatria, Hospital de Dona Estefânia, Centro Hospitalar Universitário Lisboa Central, 1169-050 Lisbon, Portugal.
Joana ArcangeloPediatric Orthopedic Unit, Área de Pediatria, Hospital de Dona Estefânia, Centro Hospitalar Universitário Lisboa Central, 1169-050 Lisbon, Portugal.
Madalena Almeida SantosLaboratory of Molecular Biology, Department of Clinical Pathology, Centro Hospitalar Universitário Lisboa Central, 1169-050 Lisbon, Portugal.
Rita Corte-RealLaboratory of Molecular Biology, Department of Clinical Pathology, Centro Hospitalar Universitário Lisboa Central, 1169-050 Lisbon, Portugal.
Maria João SimõesDepartment of Infectious Diseases, National Institute of Health Dr. Ricardo Jorge, 1600-609 Lisbon, Portugal.
Helena CanhãoNova Medical School, Faculdade de Ciências Médicas, 1169-056 Lisbon, Portugal.ORCID 0000-0003-1894-4870
Delfin TavaresPediatric Orthopedic Unit, Área de Pediatria, Hospital de Dona Estefânia, Centro Hospitalar Universitário Lisboa Central, 1169-050 Lisbon, Portugal.
Hospital de Dona Estefânia · PTUnidade Local de Saúde de São José · PTNational Institute of Health Dr. Ricardo Jorge · PTUniversidade Nova de Lisboa · PTUniversity of Lisbon · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: We aim to identify clinical and laboratorial parameters to distinguish Kingella kingae from pyogenic septic arthritis (SA). (2) Methods: A longitudinal, observational, single-centre study of children < 5 years old with microbiological positive SA admitted to a paediatric hospital from 2013−2020 was performed. Clinical and laboratorial data at admission and at 48 h, as well as on treatment and evolution, were obtained. (3) Results: We found a total of 75 children, 44 with K. kingae and 31 with pyogenic infections (mostly MSSA, S. pneumoniae and S. pyogenes). K. kingae affected younger children with low or absent fever, low inflammatory markers and a favourable prognosis. In the univariate analyses, fever, septic look, CRP and ESR at admission and CRP at 48 h were significantly lower in K. kingae SA. In the multivariate analyses, age > 6 months ≤ 2 years, apyrexy and CRP ≤ 100 mg/L were significative, with an overall predictive positive value of 86.5%, and 88.4% for K. kingae. For this model, ROC curves were capable of differentiating (AUC 0.861, 95% CI 0.767−0.955) K. kingae SA from typical pathogens. (4) Conclusions: Age > 6 months ≤ 2 years, apyrexy and PCR ≤ 100 mg/L were the main predictive factors to distinguish K. kingae from pyogenic SA < 5 years. These data need to be validated in a larger study.

Indexed as

acute septic arthritisKingella kingaepyogenic infections

Identifiers

PMID35744752
PMCPMC9227297
OpenAlexW4283022686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.